BioTek Sparkles as Diamond Sponsor at SLAS 2012
News Jan 30, 2012
BioTek Instruments will attend the premier SLAS 2012 Conference and Exhibition as a Diamond Sponsor! The exhibition will be held February 4-8, 2012 at the San Diego Convention Center in San Diego, California.
BioTek will feature their full complement of microplate instrumentation and software technologies at Booth 529 in addition to tutorials, seminars and poster presentations.
Stop by the booth to play a scavenger hunt game and a chance to win an iPad.
Featured products at the booth include BioTek’s new, cutting edge 405™ Touch Microplate Washer which boasts a high-resolution touch screen with simple protocol creation and execution for enhanced user functionality.
Additionally, two integrated USB ports allow multiple users to create and store custom protocols. 405 Touch provides the same industry-leading features as BioTek’s popular ELx405 Microplate Washer.
The monochromator-based Eon Microplate Spectrophotometer provides shaking, temperature control, flexible 200-999 nm wavelength selection, and spectral scanning in 6- to 384-well microplates.
An optional cuvette port expands functionality and aids in assay miniaturization to microplates or 2 µL volumes used with BioTek's Take3™ and new Take3 Trio Micro-Volume Plates.
Finally, the EL406™ Combination Microplate Washer Dispenser combines fast, efficient microplate washing with two dispensing technologies for 96- to 1536-well microplates, and also works with magnetic bead-based applications.
EL406 is compatible with BioTek's BioStack™ Microplate Stacker and third-party automation for unattended operation, and is controlled via the keypad interface or LHC software.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018